Results 91 to 100 of about 131,024 (143)

Acute myeloid leukemia management and research in 2025. [PDF]

CA Cancer J Clin
Kantarjian HM, DiNardo CD, Kadia TM, Daver NG, Altman JK, Stein EM, Jabbour E, Schiffer CA, Lang A, Ravandi F.   +9 more
europepmc   +1 more source

Acute Myeloid Leukemia as a Trigger for Hemolytic-Uremic Syndrome. [PDF]

J Clin Med
El Bachouti J, Domínguez-Guasch A, Arce Y, Oñate G, Marco H, Diaz M, Guirado L, Torra R, Barros X.   +8 more
europepmc   +1 more source

Long noncoding RNAs in acute myeloid leukemia: biomarkers, prognostic indicators, and treatment potential. [PDF]

Cancer Cell Int
Farajzadeh M, Fathi M, Jalali P, Mahmoudsalehi Kheshti A, Khodayari S, Hojjat-Farsangi M, Jadidi F.   +6 more
europepmc   +1 more source

Mitochondrial abnormalities as a target of intervention in acute myeloid leukemia. [PDF]

Front Oncol
Tjahjono E, Daneman MR, Meika B, Revtovich AV, Kirienko NV.   +4 more
europepmc   +1 more source

Inducing apoptosis in acute myeloid leukemia; mechanisms and limitations. [PDF]

Heliyon
Koolivand Z, Bahreini F, Rayzan E, Rezaei N.   +3 more
europepmc   +1 more source

Gilteritinib-induced pyoderma gangrenosum in a patient with acute myeloid leukemia: A case report. [PDF]

JAAD Case Rep
Sisley J, deCampos-Stairiker M, Becker SL, Throckmorton SK, Swords R, Ortega-Loayza AG.   +5 more
europepmc   +1 more source

Establishment of CD34 + hematopoietic stem cell-derived xenograft model of hyperleukocytic acute myeloid leukemia. [PDF]

BMC Cancer
Jin Y, Liang Y, Wu B, Wu S, Liu X, Zhou F.   +5 more
europepmc   +1 more source

Psychiatric and substance use disorders predict poor outcomes in older veterans with acute myeloid leukemia. [PDF]

Blood Adv
Lee MH, La J, Brophy MT, Do NV, Edwards CV, DuMontier C, Hobbs GS, Fillmore NR.   +7 more
europepmc   +1 more source